Search - tctmd.com

Displaying 1 - 20 of 873

Sort: Relevancy | Date

News Daily News

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

Yael L. Maxwell

December 02, 2025

Presentation TCT 2025

The Evolution of TAVR Explants

Presenter: Shinichi Fukuhara

October 28, 2025

Presentation TCT 2025

TCT 1228: Impact of Downsizing on Evolut Transcatheter Valve Leaflet Positioning During Valve-in-Valve: A Bench Study

Presenter: Colin Jamieson

October 27, 2025

Presentation TCT 2025

TCT 1222: Bioprosthetic Valve Fracture During VIV TAVR with a Self-Expanding Evolut Valve: Safety and Hemodynamics Outcomes from the Transcatheter Valve Therapy Registry

Presenter: Keith B. Allen

October 26, 2025

Presentation TCT 2025

TCT 1305: Evolut FX+ Implantation With a Protruding Left Main Coronary Stent

Presenter: Stephane Noble

October 26, 2025

Presentation TCT 2025

Retrograde Techniques for CTO PCI: An Evolution in Balancing Risk and Reward

Presenter: Stephane Rinfret

October 26, 2025

Presentation TCT 2025

How I Treat A Failed Evolut

Presenter: Adnan K. Chhatriwalla

October 26, 2025

Presentation TCT 2025

A New FDA for a New Era: Innovation Demands Evolution!

Presenter: Michael R. Jaff

October 25, 2025

Presentation TCT 2025

TCT 1317: Preventing Sinus Sequestration in a Failed Evolut With ShortCut: A Dedicated Leaflet Modification Device

Presenter: Bassem M. Chehab

October 25, 2025

Presentation TCT 2025

TCT 869: Comparison of Evolut FX With Latest-Generation Evolut FX+ Transcatheter Aortic Valve Systems in Real-World Practice

Presenter: Guilherme Attizzani

October 25, 2025

Presentation TCT 2025

TCT 726: Coronary Obstruction Following Transcatheter Aortic Valve Replacement Using CoreValve or Evolut in Native Aortic Stenosis: A Systematic Review

Presenter: Aoi Omori

October 25, 2025

Presentation TCT 2025

TCT 2: Win Ratio Analysis of 1-Year Outcomes in the LANDMARK Trial: Myval vs Contemporary THVs (Sapien or Evolut) in Patients with Symptomatic Severe Aortic Stenosis

Presenter: Akihiro Tobe

October 25, 2025

News Daily News

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

Caitlin E. Cox

October 16, 2025

News Conference News EACTS 2025

SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data

Yael L. Maxwell

October 10, 2025

News Features

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

Michael O'Riordan

September 17, 2025

News Conference News ESC 2025

BaxHTN: Baxdrostat Lowers BP in Uncontrolled and Resistant Hypertension

Todd Neale

August 31, 2025

News Conference News ESC 2025

DOUBLE-CHOICE: Minimalist Anesthesia for TAVI Comparable to Standard Care

Todd Neale

August 30, 2025

News Conference News ESC 2025

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

Caitlin E. Cox

August 29, 2025

FDA Expands Evolut Indication to Include Redo TAVI

News Daily News

FDA Expands Evolut Indications to Include Redo TAVI

Yael L. Maxwell

August 29, 2025

News Daily News

Balloon, Self-Expanding TAVI Devices Provide Similar Results in Bicuspid Valves

Caitlin E. Cox

August 26, 2025

Advertisement

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

The Evolution of TAVR Explants

TCT 1228: Impact of Downsizing on Evolut Transcatheter Valve Leaflet Positioning During Valve-in-Valve: A Bench Study

TCT 1222: Bioprosthetic Valve Fracture During VIV TAVR with a Self-Expanding Evolut Valve: Safety and Hemodynamics Outcomes from the Transcatheter Valve Therapy Registry

TCT 1305: Evolut FX+ Implantation With a Protruding Left Main Coronary Stent

Retrograde Techniques for CTO PCI: An Evolution in Balancing Risk and Reward

How I Treat A Failed Evolut

A New FDA for a New Era: Innovation Demands Evolution!

TCT 1317: Preventing Sinus Sequestration in a Failed Evolut With ShortCut: A Dedicated Leaflet Modification Device

TCT 869: Comparison of Evolut FX With Latest-Generation Evolut FX+ Transcatheter Aortic Valve Systems in Real-World Practice

TCT 726: Coronary Obstruction Following Transcatheter Aortic Valve Replacement Using CoreValve or Evolut in Native Aortic Stenosis: A Systematic Review

TCT 2: Win Ratio Analysis of 1-Year Outcomes in the LANDMARK Trial: Myval vs Contemporary THVs (Sapien or Evolut) in Patients with Symptomatic Severe Aortic Stenosis

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

BaxHTN: Baxdrostat Lowers BP in Uncontrolled and Resistant Hypertension

DOUBLE-CHOICE: Minimalist Anesthesia for TAVI Comparable to Standard Care

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

FDA Expands Evolut Indications to Include Redo TAVI

Balloon, Self-Expanding TAVI Devices Provide Similar Results in Bicuspid Valves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content